Lupin completes acquisition of VISUfarma EP News Bureau Apr 2, 2026 The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to over 60 branded products spanning dry eye, glaucoma,…
M&A in pharma sees deals worth $14.8 bn in Nov 2024 EP News Bureau Dec 9, 2024 According to GlobalData, M&A deal value declined by 2 per cent, and venture capital investments decreased by 5 per cent in…
